Polyphor contributes to the progress in understanding Neutrophil Elastase Science
Polyphor Ltd. in collaboration with academic groups presented on July 7th three posters related to Neutrophil Elastase (…
Polyphor Ltd. in collaboration with academic groups presented on July 7th three posters related to Neutrophil Elastase (…
Polyphor Ltd., a clinical stage, privately held Swiss specialty pharma company focused on the development of macrocycle…
Polyphor Ltd today announced the successful completion of its clinical Phase I study with inhaled POL6014 in healthy vol…
Polyphor Ltd today announced an agreement with Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), Bethesda, Md., to ad…